• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Obesity significantly associated with knee osteoarthritis

byDeepti ShroffandDavid Wang
December 18, 2015
in Chronic Disease, Public Health
Reading Time: 2 mins read
Placebo formulation impacts effectiveness of pain control in osteoarthritis
Share on FacebookShare on Twitter

1. In a meta-analysis of 14 prospective studies, increased body mass index (BMI) was a significant risk factor for knee osteoarthritis (OA).

2. BMI was found to be an independent predictor of knee OA, regardless of gender, sex, age, country, or duration of follow-up.

Evidence Rating Level: 2 (Good)          

Study Rundown: OA is a degenerative disease which is characterized tenderness, joint pain, stiffness, limited mobility, joint deformities, and swelling. Currently, it is the most common form of arthritis in the knee and affects 20 million people in the United States. Obesity has been previously associated with an increased risk of developing knee OA. However, previous meta-analysis included both cohort and case-control studies, which may limit the accuracy of the true effect size of increased obesity on OA. The purpose of this study was to clarify this association.

The authors performed a meta-analysis on 14 prospective trials on obesity and knee OA. At the conclusion of the study, increased BMI was associated with a significant increase in knee OA. In terms of effect size, the risk of OA increased by 35% for every 5 kg/m2 increase in BMI. Additionally, subgroups analyses demonstrated that the increased risk persisted regardless of gender, sex, age, country, or duration of follow-up. The results of the study suggest that it is important for physicians to consider obesity as one of the most crucial factors for development of OA. Although the limitations of this study was that it was performed with a small sample size of participants within a small number of studies, random-effect models were applied to the data to avoid overstating the level of precision.

Click to read the study in BMJ Open

RELATED REPORTS

Low-dose radiotherapy may be effective as a short-term therapeutic option in knee osteoarthritis

Prognostic associations of anthropometric indices vary by clinical outcomes

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

Relevant Reading: Obesity and Knee Osteoarthritis: The Framingham Study

In-Depth [ meta-analysis]: The meta-analysis identified 14 prospective studies from English-language journals published before August 2014. All studies calculated BMI according to the World Health Organization categorization (overweight: 25.0-29.9 kg/m2; obese over 30.0 kg/m2). The quality of studies were assessed by the Newcastle-Ottawa-Scale (NOS). Each study was reviewed by two independent investigators. At the conclusion of the trial, the relative risk of knee OA for patients who are overweight and obese were 2.45 (95% CI 1.88 to 3.20, p<0.001) and 4.55 (95% CI 2.90 to 7.13, p<0.001), respectively. Furthermore, for every 5 kg/m2 incremental increase of BMI, the risk of knee OA increased by 35%. In subgroup analysis, the increased risk of knee OA in overweight and obese patients remained regardless of study country, duration of follow-up, or gender.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: BMIobesityosteoarthritis
Previous Post

Risk factors for breast cancer-associated lymphedema may be fewer than previously reported

Next Post

Military traumatic brain injury associated with white matter abnormalities on MRI

RelatedReports

Chronic Disease

Low-dose radiotherapy may be effective as a short-term therapeutic option in knee osteoarthritis

October 8, 2026
Cardiology

Prognostic associations of anthropometric indices vary by clinical outcomes

September 28, 2026
Increasing maternal BMI linked to higher risk of cerebral palsy
Endocrinology

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

August 31, 2026
Uninterrupted warfarin therapy safe for endovascular procedures
Orthopedic Surgery

Joint fusion superior to watchful waiting for hallux rigidus 

August 10, 2026
Next Post
MRI reveals evolution of cerebral microhemorrhages in traumatic brain injury

Military traumatic brain injury associated with white matter abnormalities on MRI

Pediatric cardiac surgery occurring at earlier age, with better outcomes over 50+ year review

Cancer, prior abdominal surgery linked to readmission after hysterectomy

Anti-TNF therapy for inflammatory bowel disease may induce skin lesions

2 Minute Medicine Rewind December 21, 2015

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind October 12, 2026
  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.